512 related articles for article (PubMed ID: 20923244)
21. Pharmacokinetics of fixed-dose combinations of empagliflozin/metformin compared with individual tablets in healthy subjects.
Rojas C; Link J; Meinicke T; Macha S
Int J Clin Pharmacol Ther; 2016 Apr; 54(4):282-92. PubMed ID: 26932302
[TBL] [Abstract][Full Text] [Related]
22. Bioequivalence, Food Effect, and Steady-State Assessment of Dapagliflozin/Metformin Extended-release Fixed-dose Combination Tablets Relative to Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Subjects.
Chang M; Liu X; Cui D; Liang D; LaCreta F; Griffen SC; Lubin S; Quamina-Edghill D; Boulton DW
Clin Ther; 2015 Jul; 37(7):1517-28. PubMed ID: 26048185
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic Variables of Dapagliflozin/Metformin Extended-release Fixed-dose Combination in Healthy Chinese Volunteers and Regional Comparison.
Zhao X; Ning R; Hui A; Boulton DW; Tang W
Clin Ther; 2023 Aug; 45(8):762-769. PubMed ID: 37442656
[TBL] [Abstract][Full Text] [Related]
25. Effect of food on the pharmacokinetics of canagliflozin/metformin (150/1,000 mg) immediate-release fixed-dose combination tablet in healthy participants.
Murphy J; Wang SS; Stieltjes H; Wajs E; Devineni D
Int J Clin Pharmacol Ther; 2015 Mar; 53(3):256-64. PubMed ID: 25546166
[TBL] [Abstract][Full Text] [Related]
26. Bioequivalence of saxagliptin/metformin extended-release (XR) fixed-dose combination tablets and single-component saxagliptin and metformin XR tablets in healthy adult Chinese subjects.
Gummesson A; Li H; Gillen M; Xu J; Niazi M; Hirshberg B
Clin Drug Investig; 2014 Nov; 34(11):763-72. PubMed ID: 25269885
[TBL] [Abstract][Full Text] [Related]
27. Sitagliptin/metformin fixed-dose combination: in patients with type 2 diabetes mellitus.
Chwieduk CM
Drugs; 2011 Feb; 71(3):349-61. PubMed ID: 21319871
[TBL] [Abstract][Full Text] [Related]
28. Relative bioavailability of an empagliflozin 25-mg/linagliptin 5-mg fixed-dose combination tablet
.
Glund S; Mattheus M; Runge F; Rose P; Friedrich C
Int J Clin Pharmacol Ther; 2017 Apr; 55(4):355-367. PubMed ID: 28290274
[TBL] [Abstract][Full Text] [Related]
29. Effects of food on the pharmacokinetics of gemigliptin/metformin sustained-release 50/1,000 mg (25/500 mg x 2 tablets) fixeddose combination tablet in healthy male volunteers.
Choi HY; Noh YH; Kim YH; Kim MJ; Lee SH; Kim JA; Kim B; Lim HS; Bae KS
Int J Clin Pharmacol Ther; 2014 May; 52(5):381-91. PubMed ID: 24495314
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and Bioequivalence of Sitagliptin Phosphate/Metformin Hydrochloride Tablets in Healthy Chinese Subjects: A Randomized, Open-Label, Crossover Study.
Shi P; Liu X; Li T; Sun FF; Liu YP; Liu SQ; Gao XM; Ma YP; Fu Y; Cao Y
Drugs R D; 2022 Mar; 22(1):15-23. PubMed ID: 34850368
[TBL] [Abstract][Full Text] [Related]
31. Janumet: a combination product suitable for use in patients with Type 2 diabetes.
Reynolds JK; Neumiller JJ; Campbell RK
Expert Opin Investig Drugs; 2008 Oct; 17(10):1559-65. PubMed ID: 18808315
[TBL] [Abstract][Full Text] [Related]
32. Comparative oral bioavailability of non-fixed and fixed combinations of artesunate and amodiaquine in healthy Indian male volunteers.
Fortin A; Verbeeck RK; Jansen FH
Eur J Clin Pharmacol; 2011 Mar; 67(3):267-75. PubMed ID: 20949263
[TBL] [Abstract][Full Text] [Related]
33. Fixed-Dose Combination of Dapagliflozin + Sitagliptin + Metformin in Patients with Type 2 Diabetes Poorly Controlled with Metformin: Phase 3, Randomized Comparison with Dual Combinations.
Sahay RK; Giri R; Shembalkar JV; Gupta SK; Mohan B; Kurmi P; Kumar SR; Sawardekar VM; Mishra A; Murthy LS; Arya VV; Sonawane AR; Soni PN; Gofne SK; Karnawat SR; Rajurkar MN; Patel PM; Lakhwani LK; Mehta SC; Joglekar SJ
Adv Ther; 2023 Jul; 40(7):3227-3246. PubMed ID: 37258803
[TBL] [Abstract][Full Text] [Related]
34. Bioequivalence of Ertugliflozin/Sitagliptin Fixed-Dose Combination Tablets and Coadministration of Respective Strengths of Individual Components.
Fediuk DJ; Matschke K; Liang Y; Pelletier KB; Wei H; Shi H; Bass A; Hickman A; Terra SG; Zhou S; Krishna R; Sahasrabudhe V
Clin Pharmacol Drug Dev; 2019 Oct; 8(7):884-894. PubMed ID: 31219248
[TBL] [Abstract][Full Text] [Related]
35. Relative bioavailability study of linagliptin/metformin tablets in healthy Chinese subjects.
Pichereau S; Zhao X; Cui Y; Zhao S; Hohl K; Meinicke T; Friedrich C
Int J Clin Pharmacol Ther; 2015 Jul; 53(7):582-92. PubMed ID: 26073354
[TBL] [Abstract][Full Text] [Related]
36. Bioequivalence and food effect assessment for vildagliptin/metformin fixed-dose combination tablets relative to free combination of vildagliptin and metformin in Japanese healthy subjects.
Mita S; Chitnis SD; Kulmatycki K; Salunke A; He YL; Zhou W; Suzuki H
Int J Clin Pharmacol Ther; 2016 Apr; 54(4):305-14. PubMed ID: 26932305
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic drug interaction between gemfibrozil and sitagliptin in healthy Indian male volunteers.
K P A; Meda VS; Kucherlapati VS; Dubala A; M D; P R AV; K E; B S
Eur J Clin Pharmacol; 2012 May; 68(5):709-14. PubMed ID: 22173280
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets.
Ghim JL; Phuong NTT; Kim MJ; Kim EJ; Song GS; Ahn S; Shin JG; Kim EY
Drug Des Devel Ther; 2019; 13():1623-1632. PubMed ID: 31190741
[No Abstract] [Full Text] [Related]
39. Bioequivalence of Dapagliflozin/Metformin Extended-release Fixed-combination Drug Product and Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Russian Subjects.
Khomitskaya Y; Tikhonova N; Gudkov K; Erofeeva S; Holmes V; Dayton B; Davies N; Boulton DW; Tang W
Clin Ther; 2018 Apr; 40(4):550-561.e3. PubMed ID: 29548719
[TBL] [Abstract][Full Text] [Related]
40. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
